Tuesday 11 December, 2018
Edition: English (US)
MMJ Observer
Tag Archives: OTCMKTS:PMCB

Pharmacyte Biotech Inc (OTCMKTS:PMCB) currently working on its Investigational New Drug application and has sought the expertise of cGMP Validation to ensure that they submit a flawless masterpiece to the U.S Food and Drug Administration (FDA)...

By Jaime Williams on Dec 6th, 2018
Pharmacyte Biotech Inc

Pharmacyte Biotech Inc (OTCMKTS:PMCB) announced that Eurofins Lancaster Laboratories, a major Contract Manufacturing Organization that company selected to set its Master Cell Bank, has successfully concluded its independent growth assessment...

By Jaime Williams on Dec 1st, 2017

Pharmacyte Biotech Inc (OTCMKTS:PMCB) reported that its senior management will attend the annual meeting of the ASCO. The theme of this meeting is focused on bringing a difference in cancer care. Kenneth L. Waggoner, the CEO, reported that this...

By Brandon Manns on Jun 5th, 2017

Pharmacyte Biotech Inc (OTCMKTS:PMCB), one of the top clinical stage biotechnology companies that has done much towards developing targeted treatments for diabetes and cancer has been hitting headlines lately for the positive steps it has been...

By Elizabeth Jackson on Mar 22nd, 2017
Pharmacyte Biotech Inc

Pharmacyte Biotech Inc (OTCMKTS:PMCB) a clinical phase biotechnology firm focused on advancing targeted treatments for diabetes and cancer utilizing its signature live-cell encapsulation know-how named as Cell-in-a-Box® reported that recent...

By Elizabeth Jackson on Dec 28th, 2016
Pharmacyte Biotech Inc

Things are going as planned for Pharmacyte Biotech Inc (OTCMKTS:PMCB) and its imminent human clinical study in advanced pancreatic cancer. Just a week after the U.S. FD) granted the company a pre-IND meeting to discuss the firm’s clinical...

By Emily Gibson on Dec 21st, 2016